SEA4US
A world-class biotechnology company in marine pharmaceutical research and development that aims to discover treatments to respond to unmet clinical needs.
Proud Member of EARA
New Milestone Achieved in our Analgesic Program ”
This month we have completed the first round of optimization for synthesis scaleup of our lead analgesic, Sea4Pain, to a three-step reaction process compatible with GLP and GMP production.
GLP-enabled synthesis of our API was established with adequate purity and solid-state properties, no loss of efficacy and low erosion, excellent conversion and enantiomeric purity.
The produced API will enable the execution of our more advanced GLP preclinical tests.
Sea4Us is now taking forward the CMC work for GMP scaleup, followed by production of lots for the start of clinical trials in Q3 2025.
#Biotechnology #DrugDevelopment #ChronicPain #ScaleUp #ClinicalTrials #Biotecnologia #DesenvolvimentoDeMedicamentos #DorCrónica #EscalaIndustrial #EnsaiosClínicos
